Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2018 07:56 ET | Source: Exosome Diagnostics

Exosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical Laboratory

Waltham, MA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics has announced the placement of the world’s first system for exosome specific protein analysis, the Shahky system, within a large...
February 13, 2012 09:30 ET | Source: NanoGuardian

Top 10 Global Pharmaceutical Manufacturer Sets New Standard for Product Integrity With NanoGuardian

SKOKIE, IL--(Marketwire - Feb 13, 2012) - NanoGuardian™, a division of NanoInk®, Inc. that delivers on-dose brand protection solutions to fight illegal diversion and counterfeiting,...
August 04, 2011 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Present at the 2011 Canaccord Genuity Growth Conference

CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
July 26, 2011 08:00 ET | Source: Chelsea Therapeutics

Preliminary Data From Exploratory Phase II Study Demonstrates Significant Activity of Droxidopa in Adult Attention Deficit Hyperactivity Disorder (ADHD)

CHARLOTTE, N.C., July 26, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced positive top-line results of an investigator-led Phase II clinical study of...
July 22, 2011 08:30 ET | Source: Myrexis, Inc.

Myrexis Announces Executive Management Changes

SALT LAKE CITY, July 22, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
June 30, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Participate in Stifel Nicolaus 2011 Orphan Drug One-on-One Conference

SALT LAKE CITY, June 30, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that...
April 05, 2011 13:00 ET | Source: Semafore Pharmaceuticals

Semafore Pharmaceuticals Reports New Preclinical Data for Multi-Kinase, PI3K/mTOR Inhibitor SF1126 at AACR

INDIANAPOLIS, April 5, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals today announced encouraging preclinical results for its lead product candidate, SF1126, in certain B-cell malignancies. The...
April 01, 2009 08:30 ET | Source: Graymark Healthcare, Inc.

Graymark Healthcare Reports Fiscal 2008 Year End Results

OKLAHOMA CITY, April 1, 2009 (GLOBE NEWSWIRE) -- Graymark Healthcare Inc. (Nasdaq:GRMH) today announced results for the year ended December 31, 2008. During the year ended December 31, 2008, net...
February 26, 2009 06:00 ET | Source: CombiMatrix Corporation

CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test

MUKILTEO, Wash., Feb. 26, 2009 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing...
February 17, 2009 09:00 ET | Source: Tongli Pharmaceuticals (USA), Inc.

Tongli Pharmaceuticals Announces Strong Revenue and Net Income Growth in Third Quarter of Fiscal Year 2009

NEW YORK, N.Y., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Tongli Pharmaceuticals (OTCBB:TGLP), a pharmaceutical company specializing in the development, manufacture, and commercialization in the People's...

Next Page keyboard_arrow_right